Shuren Defends Tentative User Fee Agreement On The Hill
This article was originally published in The Gray Sheet
Executive Summary
Commonly paid user fees, such as the small business 510(k) submission fee, would not increase as dramatically as an overall doubling of total device user fees would suggest, argued the CDRH director, in defending a tentative FDA-industry agreement at a House hearing.
You may also be interested in...
Industry, FDA Agree On Draft User Fee Commitment Letter
Draft commitment and legislative language come one month after agreement “in principle” on MDUFA III reauthorization.
Draft User Fee Bills Aim To Streamline And Strengthen Device Regs
Details on draft legislation circulating in the House and Senate.
FDA Sets March 28 Date To Discuss Newly Published Draft User Fee Pact
The agency published its draft commitment letter and draft legislative language for user fee reauthorization March 15. A public meeting is set for the end of the month, and public comments will be accepted through April 16.